Co-Authors
This is a "connection" page, showing publications co-authored by Paul Nietert and Richard Silver.
Connection Strength
2.401
-
Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol. 2006 Feb; 33(2):263-8.
Score: 0.283
-
Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol. 2005 Jan; 32(1):51-7.
Score: 0.262
-
Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA. J Rheumatol. 2003 Jun; 30(6):1238-43.
Score: 0.235
-
Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rheumatol. 2001 Sep; 28(9):2031-7.
Score: 0.208
-
Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol. 2000 Nov; 12(6):520-6.
Score: 0.197
-
Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease. ACR Open Rheumatol. 2019 Sep; 1(7):403-411.
Score: 0.180
-
Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort. Clin Epidemiol. 2015; 7:161-8.
Score: 0.132
-
Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis. J Comput Assist Tomogr. 2014 Mar-Apr; 38(2):163-8.
Score: 0.124
-
Racial differences between blacks and whites with systemic sclerosis. Curr Opin Rheumatol. 2012 Nov; 24(6):642-8.
Score: 0.113
-
The health education for lupus study: a randomized controlled cognitive-behavioral intervention targeting psychosocial adjustment and quality of life in adolescent females with systemic lupus erythematosus. Am J Med Sci. 2012 Oct; 344(4):274-82.
Score: 0.112
-
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum. 2011 May; 63(5):1416-25.
Score: 0.102
-
Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways. Arthritis Rheum. 2007 Oct; 56(10):3468-77.
Score: 0.079
-
Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum. 2007 Jul; 56(7):2432-42.
Score: 0.078
-
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol. 2005 Oct; 32(10):1888-92.
Score: 0.069
-
Cytochrome P2 polymorphisms and susceptibility to scleroderma: comment on the article by Povey et al. Arthritis Rheum. 2001 Nov; 44(11):2705-6.
Score: 0.053
-
Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol. 1999 Nov; 26(11):2369-72.
Score: 0.046
-
Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998 Jun; 41(6):1111-8.
Score: 0.042
-
Systemic Sclerosis and Perceptions of Quality in Primary Care. Am J Med Sci. 2016 05; 351(5):447-51.
Score: 0.035
-
Rationale for anticoagulant therapy of pulmonary fibrosis. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):362-3.
Score: 0.031
-
Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol. 2007 Jun; 34(6):1277-82.
Score: 0.019